The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)benzylideneamino)-N-(thiazol-2-yl)benzenesulfonamide ID: ALA4859439
PubChem CID: 164617044
Max Phase: Preclinical
Molecular Formula: C22H20N6O5S2
Molecular Weight: 512.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncc([N+](=O)[O-])n1CCOc1cccc(/C=N\c2ccc(S(=O)(=O)Nc3nccs3)cc2)c1
Standard InChI: InChI=1S/C22H20N6O5S2/c1-16-24-15-21(28(29)30)27(16)10-11-33-19-4-2-3-17(13-19)14-25-18-5-7-20(8-6-18)35(31,32)26-22-23-9-12-34-22/h2-9,12-15H,10-11H2,1H3,(H,23,26)/b25-14-
Standard InChI Key: KQALYPOUOCHSCK-QFEZKATASA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
18.4611 -10.9495 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8738 -10.2438 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.0563 -10.2392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6228 -4.5399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2857 -4.0620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0314 -3.2812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2142 -3.2812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9598 -4.0620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1830 -4.3157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0674 -4.3153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6755 -3.7694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2362 -5.1149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6228 -5.3571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3305 -5.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3305 -6.5829 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0382 -6.9915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0357 -7.8098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7425 -8.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4512 -7.8097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4486 -6.9882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7411 -6.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1549 -6.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8640 -6.9832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8669 -7.8004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1612 -8.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1637 -9.0229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8734 -9.4298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5820 -9.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5760 -8.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5870 -10.6522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5910 -11.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9376 -11.9542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.1939 -12.7302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0112 -12.7262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2598 -11.9478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
7 8 2 0
5 6 2 0
4 5 1 0
6 7 1 0
8 4 1 0
8 9 1 0
10 11 2 0
10 12 1 0
5 10 1 0
4 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
27 2 1 0
2 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 31 2 0
M CHG 2 10 1 12 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 512.57Molecular Weight (Monoisotopic): 512.0937AlogP: 4.19#Rotatable Bonds: 10Polar Surface Area: 141.61Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.76CX Basic pKa: 3.03CX LogP: 3.58CX LogD: 3.02Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.19Np Likeness Score: -2.22
References 1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM.. (2021) Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective., 210 [PMID:33234343 ] [10.1016/j.ejmech.2020.112994 ]